• Slider Image

Cancer Genomics & Proteomics Editorial Board 2024

A. Seth Editor-in-chief, Laboratory of Molecular Pathology, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Ontario, Canada
G. J.  Delinasios Managing Editor and Executive Publisher, International Institute of Anticancer Research, Athens, Greece
L.A. Aaltonen Department of Medical Genetics, University of Helsinki, Helsinki, Finland
R. Abagyan The Scripps Research Institute, La Jolla, CA, USA
D.T. Bau Terry Fox Cancer Research Lab, China Medical University Hospital, Taichung, Taiwan
R. Clarke Vincent T. Lombardi Cancer Center, Georgetown Univ. School of Medicine, Washington, DC, USA
Α.Μ. Dubuc Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
T. Efferth Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, University of Mainz, Mainz, Germany
N.A. Ellis Department of Cellular and Molecular Medicine, University of Arizona Cancer Center, Tucson, AZ, USA
M.D. Filiou Department of Biological Applications and Technology, University of Ioannina & Biomedical Research Institute, FORTH, Ioannina, Greece
A. Facoetti Fondazione CNAO, Pavia, Italy
C.V. Forst Department of Genetics and Genomic Sciences, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
G. Glinsky Institute of Engineering in Medicine, University of California, San Diego, CA, USA
T.R. Golub Pediatric Oncology, Dana-Farber Cancer Institute, Cambridge, MA, USA
J. Gordon Department of Neuroscience, Center for Neurovirology, Temple University School of Medicine, Philadelphia, PA, USA
C.H. Heldin Ludwig Institute for Cancer Research, Uppsala, Sweden
J.D. Hoheisel Deutsches Krebsforschungszentrum, Genome Research and Bioinformatics, Heidelberg, Germany
T.H.M. Huang Department of Molecular Medicine / Institute of Biotechnology, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
S.C. Jhanwar Departments of Pathology and Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
J. Ju Translational Research Laboratory, State University of New York-Stony Brook, School of Medicine, Stony Brook, NY, USA
O.P. Kallioniemi Medical Biotechnology Group, VTT Technical Research Centre of Finland, Turku, Finland
K. Khalili College of Science and Technology, Center for Neurovirology and Cancer Biology, Temple University, Philadelphia, PA, USA
D.G. Kieback Helios Medical Center Schleswig, Schleswig, Germany
S.D. Kottaridis Department of Virology, Hellenic Anticancer Institute, Athens, Greece
Y. T. Kwon Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, Republic of Korea
B. Leyland – Jones Avera Cancer Institute, Sioux Falls, SD, USA
P. Lichter Deutsches Krebsforschungszentrum, Heidelberg, Germany
A. Lindblom Karolinska Hospital, Department of Molecular Medicine and Surgery, Stockholm, Sweden
G. Lubec Department of Pediatrics, University of Vienna, Austria
P.J. McCormick The Center for Functional Genomics, Gen*NY*Sis Center for Excellence in Cancer Genomics, University of Albany, SUNY, Rensselaer, NY, USA
F. Mitelman Department of Clinical Genetics, University Hospital, Lund, Sweden
C. Nicot Department of Microbiology, Immunology and Molecular Genetics, University of Kansas Medical Center, Kansas City, KS, USA
L. O’ Driscoll School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, Ireland
C.D. Platsoucas College of Sciences, Old Dominion University, Norfolk, VA, USA
J. Quackenbush Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA
J.S. Rader Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA
R.H. Reeves Department of Physiology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA
T. Ried Center for Cancer Research, Genetics Branch, NCI, NIH, Bethesda, MD, USA
G. Rimbach Institute of Human Nutrition and Food Science, Christian-Albrechts-Univercity, Kiel, Germany
K.D. Rodland Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA
C. Sansom The School of Crystallography, Birbeck College, University of London, London, UK
N.A. Saunders Centre for Immunology & Cancer Research, Princess Alexandra Hospital, University of Queensland, Brisbane, Australia
B.W. Schaefer Department of Oncology, University Children’s Hospital, Zurich, Switzerland
J. Schneider Universidad de Valladolid, Valladolid, Spain
O.J. Semmes Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, VA, USA
G.V. Sherbet University of Newcastle, Merz Court, Department of Electrical and Electronic Engineering, Newcastle upon Tyne, UK
S. Smith City of Hope Cancer Center, Department of Cell and Tumor Biology, Duarte, CA, USA
J.C. Strefford Cancer Science Division, Southampton General Hospital, Southampton, UK
G. Tsangaris Foundation of Biomedical Research of the Academy of Athens, Central Unit of Genomics- Proteomics, Athens, Greece
U.H. Weidle Roche Pharma Research and Early Development (pRED), Roche Diagnostics GmbH, Penzberg, Germany
H. Zhang Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA

 

Please submit your article only through our online submission system